KCNE1 (potassium voltage-gated channel subfamily E regulatory subunit 1)

2007-02-01  

Identity

HGNC
LOCATION
21q22.12
LOCUSID
ALIAS
ISK,JLNS,JLNS2,LQT2/5,LQT5,MinK
FUSION GENES

Other Information

Locus ID:

NCBI: 3753
MIM: 176261
HGNC: 6240
Ensembl: ENSG00000180509

Variants:

dbSNP: 3753
ClinVar: 3753
TCGA: ENSG00000180509
COSMIC: KCNE1

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000180509ENST00000337385P15382
ENSG00000180509ENST00000337385C7S316
ENSG00000180509ENST00000399284P15382
ENSG00000180509ENST00000399284C7S316
ENSG00000180509ENST00000399286P15382
ENSG00000180509ENST00000399286C7S316
ENSG00000180509ENST00000399289P15382
ENSG00000180509ENST00000399289C7S316
ENSG00000180509ENST00000416357P15382
ENSG00000180509ENST00000416357C7S316
ENSG00000180509ENST00000432085P15382
ENSG00000180509ENST00000432085C7S316
ENSG00000180509ENST00000611936P15382
ENSG00000180509ENST00000611936C7S316
ENSG00000180509ENST00000621601P15382
ENSG00000180509ENST00000621601C7S316

Expression (GTEx)

0
1
2
3
4
5
6

Pathways

PathwaySourceExternal ID
Adrenergic signaling in cardiomyocytesKEGGhsa04261
Adrenergic signaling in cardiomyocytesKEGGko04261
Muscle contractionREACTOMER-HSA-397014
Cardiac conductionREACTOMER-HSA-5576891
Phase 2 - plateau phaseREACTOMER-HSA-5576893
Phase 3 - rapid repolarisationREACTOMER-HSA-5576890

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA151249535diureticsChemicalClinicalAnnotationassociatedPD
PA164712406AntibioticsChemicalClinicalAnnotationassociatedPD
PA447300Acquired Long QT Syndrome (aLQTS)DiseaseLiterature, MultilinkAnnotationassociated24561134
PA448383amiodaroneChemicalClinicalAnnotationassociatedPD
PA451209quinidineChemicalClinicalAnnotationassociatedPD
PA451457sotalolChemicalClinicalAnnotationassociatedPD
PA452233antipsychoticsChemicalClinicalAnnotationassociatedPD

References

Pubmed IDYearTitleCitations
117992442002Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel.234
193054082009Common variants at ten loci influence QT interval duration in the QTGEN Study.190
158404762005Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing.177
197160852009Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test.126
164149442005Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice.119
172108392007Prevalence of long-QT syndrome gene variants in sudden infant death syndrome.106
172108392007Prevalence of long-QT syndrome gene variants in sudden infant death syndrome.106
186110412008Structure of KCNE1 and implications for how it modulates the KCNQ1 potassium channel.102
146616772003Ethnic differences in cardiac potassium channel variants: implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome.86
199131212009Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.85

Citation

Dessen P

KCNE1 (potassium voltage-gated channel subfamily E regulatory subunit 1)

Atlas Genet Cytogenet Oncol Haematol. 2007-02-01

Online version: http://atlasgeneticsoncology.org/gene/46537/kcne1